Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (12) | Back to Search
Application of QbD in biotechnology
- In: S6 - Implementation of Quality by Design and Risk Management- overcoming the practical hurdles on Thursday, 4 September 2008, 9:00-12:00
- At: Basel (Switzerland) (2008)
- Type: Presentation
- By: ADVANT, Siddharth (Sid) (Tunnell Consulting, San Diego, United States of America)
- Abstract:
The role of QbD in biotechnology is still evolving. Although companies have used DOE and PAT in process development and process characterization, their role in QbD- specifically to provide regulatory relief is still unclear. This presentation will discuss the current thinking and future potential of how QbD can be used in regulatory submissions.
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023